Are you studying or working in the healthcare industry or in computer science? Do you want to know more on how AI and ML techniques can be used to predict the quality of life and the toxicity profile of cancer patients? Then you should join ImmuneAI’s hybrid workshop on December 19th, 16.00 – 18.00 CET!
Here are the two ways to join ImmuneAI’s workshop:
- In-person: University of Brescia, Italy, – Room “A”
- Virtually on Teams: Click here to join the meeting
During this workshop, Athens Technology Center (ATC) together with UniBs and Ubitech will elaborate on ImmuneAI’s progress and significant findings. You can see the Agenda here.
For more information, contact paolo.bossi@unibs.it
ImmuneAI is an Open Call project under ASCAPE Researsh & Innovation Programme funded from the European Union’s Horizon 2020 framework under grant agreement No 875351. ImmuneAI contributed to the creation of new algorithms in order to identify, quantify and predict the Quality of Life (QoL) & the toxicity profile of patients experiencing long survival -thanks to immunotherapy treatment. The vision of the project was to reveal the patients with the greatest survival benefit in terms of QoL by retrieving baseline clinical and biological characteristics of long-term survivors with immunotherapy. 